Preparation of drug-montmorillonite UV-radiation protection compounds by gas-solid adsorption

Clay Minerals

Volumn 36, Issue 4, 2001, Pages 541-546

  Del Hoyo, C ^a   Vicente, M A ^a,b   Rives, V ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE RECURSOS NATURALES Y AGROBIOLOGÍA DE SALAMANCA   (Spain)

Author keywords

Drug clay interaction; Ethyl cinnamate; Gas solid adsorption; Montmorillonite; UV radiation protection

Indexed keywords

EID: 1842685041     PISSN: 00098558     EISSN: None     Source Type: Journal    
DOI: 10.1180/0009855013640007     Document Type: Article

References (20)

1. Cairns-Smith A.G. & Hartman H. (1986) Clay Minerals and the Origin of Life. Cambridge University Press, Cambridge.
2. Čičel B. & Kranz G. (1981) Mechanism of montmorillonite structure degradation by percussive grinding Clay Miner. 16, 151-162.
3. Del Hoyo C. (1995) Pharmaceutical/clay systems: preparation, characterization and application as ultraviolet radiation shelters PhD thesis, Univ. Salamanca, Spain
4. Del Hoyo C., Rives V. & Vicente M.A. (1996a) Adsorption of melted drugs on smectite. Clays Clay Miner. 44, 424-428.
5. Del Hoyo C., Rives V. & Vicente M.A. (1996b) Application of methyl cinnamate/montmorillonite as ultraviolet radiation shelters. Drug Dev. Ind. Pharm. 22, 1089-1095.
6. Del Hoyo C., Rives V. & Vicente M A. (1998) Application of phenyl salicylate-sepiolite systems as ultraviolet radiation filters. Clay Miner. 33, 467-474.
7. Farmer V.C. (1974) The Infrared Spectra of Minerals. Monograph, 4. Mineralogical Society, London.
8. Forteza M., Galán E. & Cornejo J. (1989) Interaction of dexamethasone and montmorillonite. Adsorption-degradation process. Appl. Clay Sci. 4, 437-448.
9. Hermosín C., Cornejo J., White J.L. & Hem S.L. (1981) Sepiolite: a potential excipient for drugs subject to oxidative degradation. J. Pharm Sci. 70, 189-192.
10. MacKenzie R.C. (1970) Differencial Thermal Analysis (Vol. 1). Academic Press, London.
11. Mortland M.M. (1970) Clay-organic complexes and interactions. Adv Agron 22, 75-117
12. Porubcan J.S., Serna C J , White J L. & Hem S.L. (1978) Mechanism of adsorption of clinamycin and tetracycline by montmorillonite J. Pharm. Sci. 67, 1081-1087.
13. Rausell-Colom J.A. & Serratosa J.M. (1987) Reactions of clays with organic substances. Pp. 371-442 in: Chemistry of Clays and Clay Minerals. Monograph, 6. Mineralogical Society, London.
14. Sánchez-Martín M.J., Sánchez-Camazano M., Vicente-Hernández M.T. & Domínguez-Gil A. (1981) Interaction of propranolol hydrochloride with montmorillonite. J Pharm. Pharmacol. 33, 408-410.
15. Sayalero M.L. (1982) Study of the interaction between cardiac drugs and montmorillonite. PhD thesis, Univ. Salamanca, Spain.
16. The Merck Index (1989) 11th Ed. Centennial Edition. Merck and Co., Inc., Rahway, N.J., USA.
17. Theng B.K.G. (1974) The Chemistry of Clay-Organic Reactions. Wiley, New York.
18. Vicente M.T. (1981) Study of the interaction between adrenergic blockeants and montmorillonite. PhD thesis, Univ. Salamanca, Spain.
19. Vicente M.A., Sánchez-Camazano M., Sánchez-Martín M.J., Del Arco M., Martín C., Rives V. & Vicente-Hernández J. (1989). Adsorption and desorption of N-methyl-8-hydroxy quinoline methyl sulfate on smectite and the potential use of the clay-organic product as an ultraviolet radiation collector. Clays Clay Miner. 37, 157-163.
20. White J.L. & Hem S.L. (1983). Pharmaceutical aspects of clay-drug interactions. Ind. Eng. Chem. Prod. Res. Dev. 22, 665-671.